Sun Pharmaceutical Industries Ltd vs Span Divergent Ltd

A side-by-side comparison of Sun Pharmaceutical Industries Ltd (MIL) and Span Divergent Ltd (SDL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Ltd leads MIL vs SDL on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth01
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.90
P/E ratio
0.00
5.35
P/B ratio
1.44
0.86%
Dividend yield
0.00%
₹0.67
EPS
₹-1.68

Profitability

MIL takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-6.70%
Return on equity
-41.50%
-1.00%
Return on capital
-30.00%
3.50%
EBITDA margin
-7.25%
-13.10%
Net margin
-14.29%

Growth

SDL takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-87.58%
Revenue CAGR (3Y)
10.52%
Profit CAGR (3Y)

Size & financial health

MIL takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.42L Cr
Market cap
₹21 Cr
₹84 Cr
Revenue
₹9 Cr
₹-11 Cr
Net profit
₹-1 Cr
0.06
Debt / equity
0.48
Sun Pharmaceutical Industries Ltd
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Span Divergent Ltd
  • + ["Debtor days have improved from 45.0 to 32.6 days."]
  • ["Company has low interest coverage ratio.", "Promoter holding has decreased over last 3 years: -15.9%"]
Sun Pharmaceutical Industries Ltd full analysis Span Divergent Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.